Home
AADI
AADI News

Latest Aadi Bioscience Inc. (AADI) News on February 23, 2025

3 US Penny Stocks With Market Caps Over $30M To Watch

Simply Wall St.

2 days ago

3 US Penny Stocks With Market Caps Over $30M To Watch

Aadi Bioscience Appoints David Dornan, PhD, as Chief Scientific Officer

PR Newswire

5 days ago

Aadi Bioscience Appoints David Dornan, PhD, as Chief Scientific Officer

Aadi Bioscience Filed Definitive Proxy Statement and Schedules Special Meeting of Stockholders for February 28, 2025

PR Newswire

17 days ago

Aadi Bioscience Filed Definitive Proxy Statement and Schedules Special Meeting of Stockholders for February 28, 2025

Aadi Bioscience Leads 3 Promising US Penny Stocks

Simply Wall St.

2 months ago

Aadi Bioscience Leads 3 Promising US Penny Stocks

Aadi Bioscience’s Strategic Agreements and Funding Moves

TipRanks

2 months ago

Aadi Bioscience’s Strategic Agreements and Funding Moves

Aadi Bioscience Transforms with In-Licensing of Novel ADC Portfolio, $100 Million Sale of FYARRO® and $100 Million PIPE Financing

PR Newswire

2 months ago

Aadi Bioscience Transforms with In-Licensing of Novel ADC Portfolio, $100 Million Sale of FYARRO® and $100 Million PIPE Financing

US Penny Stocks Under $90M Market Cap To Watch

Simply Wall St.

3 months ago

US Penny Stocks Under $90M Market Cap To Watch

Aadi Bioscience Announces Financial Results for the Third Quarter 2024 and Provides Corporate Update

PR Newswire

4 months ago

Aadi Bioscience Announces Financial Results for the Third Quarter 2024 and Provides Corporate Update

Aadi Bioscience to Report Third Quarter 2024 Results and Corporate Update

PR Newswire

4 months ago

Aadi Bioscience to Report Third Quarter 2024 Results and Corporate Update

Aadi Bioscience Provides PRECISION1 Trial and Corporate Updates

PR Newswire

6 months ago

Aadi Bioscience Provides PRECISION1 Trial and Corporate Updates

Aadi Bioscience Announces Financial Results for the Second Quarter 2024 and Provides Corporate Update

PR Newswire

7 months ago

Aadi Bioscience Announces Financial Results for the Second Quarter 2024 and Provides Corporate Update

Aadi Bioscience to Report Second Quarter 2024 Results and Corporate Update

PR Newswire

7 months ago

Aadi Bioscience to Report Second Quarter 2024 Results and Corporate Update

We're Keeping An Eye On Aadi Bioscience's (NASDAQ:AADI) Cash Burn Rate

Simply Wall St.

7 months ago

We're Keeping An Eye On Aadi Bioscience's (NASDAQ:AADI) Cash Burn Rate

Better AI Stock: Palantir vs. Snowflake

Motley Fool

8 months ago

Better AI Stock: Palantir vs. Snowflake

Is Now the Time to Buy 3 of the S&P 500's Highest-Yielding Dividend Stocks?

Motley Fool

8 months ago

Is Now the Time to Buy 3 of the S&P 500's Highest-Yielding Dividend Stocks?

BigBear.ai Stock: Buy, Sell, or Hold?

Motley Fool

8 months ago

BigBear.ai Stock: Buy, Sell, or Hold?

Indonesia's first Olympic gymnast encourages others to 'dream higher'

AFP

8 months ago

Indonesia's first Olympic gymnast encourages others to 'dream higher'

Where Will CrowdStrike Stock Be in 1 Year?

Motley Fool

8 months ago

Where Will CrowdStrike Stock Be in 1 Year?

Warren Buffett's Strategic Acquisition in Occidental Petroleum Corp

GuruFocus.com

8 months ago

Warren Buffett's Strategic Acquisition in Occidental Petroleum Corp

Insider Sale: EVP, CEO of Patient Direct, Perry Bernocchi, Sells Shares of Owens & Minor ...

GuruFocus.com

8 months ago

Insider Sale: EVP, CEO of Patient Direct, Perry Bernocchi, Sells Shares of Owens & Minor ...

A Look At The Intrinsic Value Of Deufol SE (HMSE:DE1)

Simply Wall St.

8 months ago

A Look At The Intrinsic Value Of Deufol SE (HMSE:DE1)

Aadi Bioscience to Participate in the Jefferies Healthcare Conference

PR Newswire

9 months ago

Aadi Bioscience to Participate in the Jefferies Healthcare Conference

Aadi Bioscience Presents New Nonclinical Data Demonstrating Preferential Tumor Uptake of nab-Sirolimus at the American Society of Clinical Oncology (ASCO) Annual Meeting

PR Newswire

9 months ago

Aadi Bioscience Presents New Nonclinical Data Demonstrating Preferential Tumor Uptake of nab-Sirolimus at the American Society of Clinical Oncology (ASCO) Annual Meeting

Aadi Bioscience, Inc. (NASDAQ:AADI) Analysts Are Cutting Their Estimates: Here's What You Need To Know

Simply Wall St.

9 months ago

Aadi Bioscience, Inc. (NASDAQ:AADI) Analysts Are Cutting Their Estimates: Here's What You Need To Know

Analysts Just Made A Major Revision To Their Aadi Bioscience, Inc. (NASDAQ:AADI) Revenue Forecasts

Simply Wall St.

9 months ago

Analysts Just Made A Major Revision To Their Aadi Bioscience, Inc. (NASDAQ:AADI) Revenue Forecasts

Aadi Bioscience First Quarter 2024 Earnings: US$0.68 loss per share (vs US$0.57 loss in 1Q 2023)

Simply Wall St.

9 months ago

Aadi Bioscience First Quarter 2024 Earnings: US$0.68 loss per share (vs US$0.57 loss in 1Q 2023)

Aadi Bioscience Announces Financial Results for the First Quarter 2024 and Provides Corporate Update

PR Newswire

9 months ago

Aadi Bioscience Announces Financial Results for the First Quarter 2024 and Provides Corporate Update

Aadi Bioscience to Report First Quarter 2024 Results and Corporate Update

PR Newswire

10 months ago

Aadi Bioscience to Report First Quarter 2024 Results and Corporate Update

Aadi Bioscience to Present New Non-clinical Data Highlighting Combinability of nab-Sirolimus at the American Association for Cancer Research (AACR) Annual Meeting

PR Newswire

10 months ago

Aadi Bioscience to Present New Non-clinical Data Highlighting Combinability of nab-Sirolimus at the American Association for Cancer Research (AACR) Annual Meeting

Aadi Bioscience Presents New Subgroup Analysis of Patients with Advanced Malignant PEComa of Gynecologic Origin Treated with nab-Sirolimus at Society of Gynecologic Oncology (SGO)

PR Newswire

a year ago

Aadi Bioscience Presents New Subgroup Analysis of Patients with Advanced Malignant PEComa of Gynecologic Origin Treated with nab-Sirolimus at Society of Gynecologic Oncology (SGO)

Aadi Bioscience Full Year 2023 Earnings: US$2.44 loss per share (vs US$2.69 loss in FY 2022)

Simply Wall St.

a year ago

Aadi Bioscience Full Year 2023 Earnings: US$2.44 loss per share (vs US$2.69 loss in FY 2022)

Aadi Bioscience Announces Financial Results for the Fourth Quarter and Full-Year 2023 and Provides Corporate Update

PR Newswire

a year ago

Aadi Bioscience Announces Financial Results for the Fourth Quarter and Full-Year 2023 and Provides Corporate Update

Aadi Bioscience to Report Fourth Quarter and Full-Year 2023 Results and Corporate Update

PR Newswire

a year ago

Aadi Bioscience to Report Fourth Quarter and Full-Year 2023 Results and Corporate Update

Aadi Bioscience to Present Multiple Posters at the American Association for Cancer Research (AACR) Annual Meeting 2024

PR Newswire

a year ago

Aadi Bioscience to Present Multiple Posters at the American Association for Cancer Research (AACR) Annual Meeting 2024

Aadi Bioscience Announces Publication of Long-Term Efficacy and Safety Data Further Supporting FYARRO® for the Treatment of Malignant PEComa

PR Newswire

a year ago

Aadi Bioscience Announces Publication of Long-Term Efficacy and Safety Data Further Supporting FYARRO® for the Treatment of Malignant PEComa

Aadi Bioscience to Present at the TD Cowen 44th Annual Healthcare Conference

PR Newswire

a year ago

Aadi Bioscience to Present at the TD Cowen 44th Annual Healthcare Conference

Dow Futures Trade Higher Ahead of Jobs Report

Barrons.com

a year ago

Dow Futures Trade Higher Ahead of Jobs Report

Palatin Announces Closing of $10 Million Registered Direct Offering

PR Newswire

a year ago

Palatin Announces Closing of $10 Million Registered Direct Offering

NMG Announces the Successful Closing of the Previously Announced Acquisition of Mason Resources’ Lac Guéret Graphite Deposit/Uatnan Mining Project – One of the World’s Largest Graphite Projects in Development

Business Wire

a year ago

NMG Announces the Successful Closing of the Previously Announced Acquisition of Mason Resources’ Lac Guéret Graphite Deposit/Uatnan Mining Project – One of the World’s Largest Graphite Projects in Development

Aadi Bioscience Announces Poster Presentations at the 2024 American Society of Clinical Oncology (ASCO) Genitourinary (GU) Cancers Symposium

PR Newswire

a year ago

Aadi Bioscience Announces Poster Presentations at the 2024 American Society of Clinical Oncology (ASCO) Genitourinary (GU) Cancers Symposium

Celularity and Genting Leaders Comments on Closing $21 Million Financing Transactions

GlobeNewswire

a year ago

Celularity and Genting Leaders Comments on Closing $21 Million Financing Transactions

Zentek Completes Study Quantifying Energy and Emission Savings of ZenGUARD(TM)-Enhanced HVAC Filters

ACCESSWIRE

a year ago

Zentek Completes Study Quantifying Energy and Emission Savings of ZenGUARD(TM)-Enhanced HVAC Filters

Aadi Bioscience Announces Poster Presentations at the 2024 American Society of Clinical Oncology (ASCO) Gastrointestinal (GI) Cancers Symposium

PR Newswire

a year ago

Aadi Bioscience Announces Poster Presentations at the 2024 American Society of Clinical Oncology (ASCO) Gastrointestinal (GI) Cancers Symposium

Celularity Releases CEO Letter to Shareholders

GlobeNewswire

a year ago

Celularity Releases CEO Letter to Shareholders

iHeartMedia and FOX Entertainment Announce Nominees for the 2024 iHeartRadio Music Awards

Business Wire

a year ago

iHeartMedia and FOX Entertainment Announce Nominees for the 2024 iHeartRadio Music Awards

GreenPower Announces Delivery of 10 EV Star Cab and Chassis to Global Retailer in Canada

PR Newswire

a year ago

GreenPower Announces Delivery of 10 EV Star Cab and Chassis to Global Retailer in Canada

Celularity Confirms Commercialization Agreement with BioCellgraft for the Manufacture and Distribution of Advanced Biomaterial Products for Use in Oral Healthcare

GlobeNewswire

a year ago

Celularity Confirms Commercialization Agreement with BioCellgraft for the Manufacture and Distribution of Advanced Biomaterial Products for Use in Oral Healthcare

Billionaire Louis Bacon’s 15 Long-Term Stock Picks

Insider Monkey

a year ago

Billionaire Louis Bacon’s 15 Long-Term Stock Picks

Celularity Announces Net Sales and Total Revenue Expectations for Fourth Quarter 2023 and Full Year 2023

GlobeNewswire

a year ago

Celularity Announces Net Sales and Total Revenue Expectations for Fourth Quarter 2023 and Full Year 2023

G1 Therapeutics to Participate in the 42nd Annual J.P. Morgan Healthcare Conference

GlobeNewswire

a year ago

G1 Therapeutics to Participate in the 42nd Annual J.P. Morgan Healthcare Conference

Should Value Investors Buy Capital Bancorp (CBNK) Stock?

Zacks

a year ago

Should Value Investors Buy Capital Bancorp (CBNK) Stock?

NKGen Biotech Advances Alzheimer's Treatment with SNK01: First Patient Dosed in Phase 1/2a Trial

News Direct

a year ago

NKGen Biotech Advances Alzheimer's Treatment with SNK01: First Patient Dosed in Phase 1/2a Trial

4 Top-Ranked Auto Stocks That Crushed the Market in 2023

Zacks

a year ago

4 Top-Ranked Auto Stocks That Crushed the Market in 2023

Should You Invest in Bluebird Bio Right Now?

Motley Fool

a year ago

Should You Invest in Bluebird Bio Right Now?

Complete Solaria Announces an Equity Investment from Its Chairman

GlobeNewswire

a year ago

Complete Solaria Announces an Equity Investment from Its Chairman

Expensify Adds Budgeting to Help Companies Prepare for 2024

Business Wire

a year ago

Expensify Adds Budgeting to Help Companies Prepare for 2024

3 Penny Stocks That Are Too Compelling to Ignore

InvestorPlace

a year ago

3 Penny Stocks That Are Too Compelling to Ignore

PR Newswire

a year ago

JOHN HANCOCK CLOSED-END FUNDS ANNOUNCE RENEWAL OF SHARE REPURCHASE PLANS

Aadi Bioscience Reports Interim Results from PRECISION1 Trial of nab-Sirolimus Demonstrating Anti-Tumor Activity in Solid Tumors with TSC1 or TSC2 Inactivating Alterations

PR Newswire

a year ago

Aadi Bioscience Reports Interim Results from PRECISION1 Trial of nab-Sirolimus Demonstrating Anti-Tumor Activity in Solid Tumors with TSC1 or TSC2 Inactivating Alterations

GreenPower Delivers Four Nano BEAST All-Electric, School Buses to West Virginia School Districts

CNW Group

a year ago

GreenPower Delivers Four Nano BEAST All-Electric, School Buses to West Virginia School Districts

There’s an EV Delivery Event Today. It’s Different From the Cybertruck One.

Barrons.com

a year ago

There’s an EV Delivery Event Today. It’s Different From the Cybertruck One.

GreenPower Announces Production of its First All-Electric School Buses at West Virginia Manufacturing Facility

PR Newswire

a year ago

GreenPower Announces Production of its First All-Electric School Buses at West Virginia Manufacturing Facility

Aadi Bioscience, Inc. (NASDAQ:AADI) is definitely on the radar of institutional investors who own 39% of the company

Simply Wall St.

a year ago

Aadi Bioscience, Inc. (NASDAQ:AADI) is definitely on the radar of institutional investors who own 39% of the company

Complete Solaria Appoints Solar Industry Veteran and Growth Expert Chris Lundell as its New CEO

GlobeNewswire

a year ago

Complete Solaria Appoints Solar Industry Veteran and Growth Expert Chris Lundell as its New CEO

GreenPower Panel Shares Real-World Experiences from Deploying the Type A Nano BEAST in Special Needs Situations

CNW Group

a year ago

GreenPower Panel Shares Real-World Experiences from Deploying the Type A Nano BEAST in Special Needs Situations

GreenPower Announces First Order of Nano BEAST All-Electric School Buses for the New York Market

CNW Group

a year ago

GreenPower Announces First Order of Nano BEAST All-Electric School Buses for the New York Market

PR Newswire

a year ago

JOHN HANCOCK CLOSED-END FUNDS DECLARE QUARTERLY DISTRIBUTIONS

Hubzu Expands Collaboration with NCST (National Community Stabilization Trust) to Increase Access to Affordable Housing

GlobeNewswire

a year ago

Hubzu Expands Collaboration with NCST (National Community Stabilization Trust) to Increase Access to Affordable Housing

Ocugen CEO to Present at NobleCon19 – Noble Capital Markets’ Nineteenth Annual Emerging Growth Equity Conference

GlobeNewswire

a year ago

Ocugen CEO to Present at NobleCon19 – Noble Capital Markets’ Nineteenth Annual Emerging Growth Equity Conference

Complete Solaria Announces Will Anderson to Remain Interim CEO

GlobeNewswire

a year ago

Complete Solaria Announces Will Anderson to Remain Interim CEO

Celularity Inc. Announces Receipt of Nasdaq Notice Regarding Late Form 10-Q Filing

GlobeNewswire

a year ago

Celularity Inc. Announces Receipt of Nasdaq Notice Regarding Late Form 10-Q Filing

PR Newswire

a year ago

JOHN HANCOCK CLOSED-END FUNDS RELEASE EARNINGS DATA

Complete Solaria Reports Third Quarter 2023 Results

GlobeNewswire

a year ago

Complete Solaria Reports Third Quarter 2023 Results

Biodesix Enhances Access to Nodify Lung® Testing with Launch of New Blood Draw Method

Business Wire

a year ago

Biodesix Enhances Access to Nodify Lung® Testing with Launch of New Blood Draw Method

Verde Clean Fuels, Inc. Reports Third Quarter 2023 Earnings

Business Wire

a year ago

Verde Clean Fuels, Inc. Reports Third Quarter 2023 Earnings

Spruce Power Holding Corporation (NYSE:SPRU) Q3 2023 Earnings Call Transcript

Insider Monkey

a year ago

Spruce Power Holding Corporation (NYSE:SPRU) Q3 2023 Earnings Call Transcript

Hyperfine, Inc. Reports Third Quarter 2023 Financial Results

GlobeNewswire

a year ago

Hyperfine, Inc. Reports Third Quarter 2023 Financial Results

Aadi Bioscience Reports Financial Results for the Third Quarter 2023 and Provides Corporate Update

PR Newswire

a year ago

Aadi Bioscience Reports Financial Results for the Third Quarter 2023 and Provides Corporate Update

7 Stocks to Buy if You Anticipate a Hot November

InvestorPlace

a year ago

7 Stocks to Buy if You Anticipate a Hot November

Aadi Bioscience to Participate in Jefferies London Healthcare Conference

PR Newswire

a year ago

Aadi Bioscience to Participate in Jefferies London Healthcare Conference

Complete Solaria to Report Third Quarter 2023 Earnings on November 14, 2023

GlobeNewswire

a year ago

Complete Solaria to Report Third Quarter 2023 Earnings on November 14, 2023

Share on Social Networks: